Efficacy of Elaeagnus multiflora and Cynanchum wilfordii Complex Extract on Male Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
The World Journal of Men's Health · 2026 · 44 (4) · 1066
DOI: 10.5534/wjmh.250239 ↗Kurz gefasst
Fachartikel in der Zeitschrift The World Journal of Men's Health, 2026. Verfasst von Hwa Jong Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Medical Sciences, The Catholic University of Korea, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Functional Specialty Resources Industrialization Phase 3 Project, Ministry of SMEs and Startups.
Abstract (Originalsprache)
PURPOSE: Lower urinary tract symptoms (LUTS) in men substantially impair quality of life and are commonly treated with alpha-blockers or 5-alpha reductase inhibitors, which may cause adverse effects. Elaeagnus multiflora and Cynanchum wilfordii, traditional herbal remedies, have shown potential benefits in testosterone regulation and benign prostatic hyperplasia (BPH); however, clinical evidence supporting their efficacy in LUTS remains limited. This study evaluated the efficacy and safety of the E. multiflora and C. wilfordii complex (NET1701) in men with LUTS. MATERIALS AND METHODS: In this randomized, double-blind, placebo-controlled trial, 100 men aged 40-80 years with moderate LUTS (International Prostate Symptom Score [IPSS] 8-19) were randomized to receive NET1701 (325 mg/d) or placebo for 12 weeks. The primary outcome was the change in total IPSS from baseline to 12 weeks. Secondary outcomes included IPSS subscores, maximum urinary flow rate (Qmax), post-void residual volume (PVR), serum testosterone levels, and safety. RESULTS: At 12 weeks, the NET1701 group showed a significantly greater reduction in total IPSS compared with placebo (-5.67±3.86 vs. -1.00±4.30; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Medical Sciences, The Catholic University of Korea, Seoul, Korea.
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Green Medicine Co., Ltd, Busan, Korea.
- Herbal Hormone Research Institute, Naturalendo Tech Co., Ltd., Seongnam, Korea.
- Jeonnam Institute of Natural Resources Research (JINR), Jeonnam Bio Foundation, Jangheung, Korea.
ORCID-Profile: Hwa Jong Lee, Tae Hyung Kim, Soomin Kim, Hyuk Jin Cho, U-Syn Ha, Sae Woong Kim, Ha-Neul Jo, Jaeyong Kim, Dongho Shin, Woong Jin Bae
Förderung
- Functional Specialty Resources Industrialization Phase 3 Project
- Ministry of SMEs and Startups
Zitieren
APA
Lee, H. J., Kim, T. H., Kim, S., Cho, H. J., Ha, U. S., Kim, S. W., Jo, H. N., Kim, J., Shin, D., & Bae, W. J. (2026). Efficacy of Elaeagnus multiflora and Cynanchum wilfordii Complex Extract on Male Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. The World Journal of Men's Health, 44(4), 1066. https://doi.org/10.5534/wjmh.250239
Vancouver
Lee HJ, Kim TH, Kim S, Cho HJ, Ha US, Kim SW, et al. Efficacy of Elaeagnus multiflora and Cynanchum wilfordii Complex Extract on Male Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. The World Journal of Men's Health. 2026;44(4):1066. doi:10.5534/wjmh.250239
BibTeX
@article{Lee2026,
author = {Lee, Hwa Jong and Kim, Tae Hyung and Kim, Soomin and Cho, Hyuk Jin and Ha, U-Syn and Kim, Sae Woong and Jo, Ha-Neul and Kim, Jaeyong and Shin, Dongho and Bae, Woong Jin},
title = {Efficacy of Elaeagnus multiflora and Cynanchum wilfordii Complex Extract on Male Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial},
journal = {The World Journal of Men's Health},
year = {2026},
volume = {44},
number = {4},
pages = {1066},
doi = {10.5534/wjmh.250239}
}
EUVIMED